Recombinant Vaccines Market | 2021 Healthcare Industry Analysis By COVID-19 Impact Forecast By Size, Growth, Share Estimation, Business, And Global Trends Analysis To 2026

Posted on Jan 27 2021 10:44 AM

"Recombinant Vaccines Market | 2021 COVID-19 Impact On Healthcare Industry Size, Growth Rate, Business, Share Estimation, Trends, and Regional Forecast To 2026 is latest Report published by Fortune Business Insights. Global Recombinant Vaccines Market is forecast to grow at moderate Compound Annual Growth Rate And Will Reach Notable Market Value By 2026. Report analyzes market for Recombinant Vaccines By Asia, North America, Europe, Africa, South America, Australia. Global Recombinant Vaccines market report provides comprehensive information on supply and demand Figures, cost, price, revenue and gross margins with exclusive statistics, data, and competitive landscape details in this niche sector."

Recombinant Vaccines Market | 2021 COVID-19 Impact On Healthcare Industry Size, Growth Rate, Business, Share Estimation, Trends, and Regional Forecast To 2026 is latest Report published by Fortune Business Insights. Global Recombinant Vaccines Market is forecast to grow at moderate Compound Annual Growth Rate And Will Reach Notable Market Value By 2026. Report analyzes market for Recombinant Vaccines By Asia, North America, Europe, Africa, South America, Australia. Global Recombinant Vaccines market report provides comprehensive information on supply and demand Figures, cost, price, revenue and gross margins with exclusive statistics, data, and competitive landscape details in this niche sector.

Get Sample Copy of Global Recombinant Vaccines Market Forecast Report 2021 To 2026

Recombinant Vaccines Market Analysis 2021:

The global recombinant vaccines market size is expected to reach USD 25.32 billion by 2027, exhibiting a CAGR of 11.3% between 2019 to 2027. The introduction of innovative recombinant vaccines owing to the incidence of several infectious viruses such as coronavirus and hepatitis B will uplift the market potential during the forecast period. The market size stood at USD 10.82 billion in 2019.

 Global Recombinant Vaccines Market Key Players Analyzed In Report:

GlaxoSmithKline plc., Merck & Co., Inc, Dynavax Technologies, Pfizer Inc, Sanofi S.A, Serum Institute of India Pvt. Ltd, Novartis AG and other key market players.

 Recombinant Vaccines Market segmented By Type (Subunit and Live Attenuated), By Route of Administration (Parenteral and Oral), By Disease Indication (Human Papillomavirus (HPV), Hepatitis B, Rotavirus, Herpes Zoster, Meningococcal B, and Others), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers and Others) and Geography Forecast, 2020-2027.

The growing prevalence of diseases and viruses has led to huge investments in R&D for the development of innovative drugs and vaccines. The production of vaccines in larger quantities to relieve the population and prevent the risk of vaccine unavailability. The rising focus of key players towards advanced DNA technology, genomics, and other biotechnology techniques can further enhance the production and thus, benefit the market effectively.

The Global Recombinant Vaccines market report is provided for the international markets as well as development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report additionally states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

Furthermore, the stellar sales of novel products will subsequently boost the growth of the market. For instance, Merck’s Gardasil sales sprouted to US$ 3.7 billion in 2019 from US$ 1.7 billion in 2014. The vast majority of the population affected by Hepatitis B is predicted to be an essential factor in promoting the expansion of the market. As per the Hepatitis B Foundation, every year 30 million people are infected by the hepatitis B virus. Besides, the rising government initiatives and immunization programs will certainly create opportunities for the market in the forthcoming years.

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market. Furthermore, the report offers a detailed analysis and information as per Recombinant Vaccines Market Growth Analysis by manufacturers, market segments helping our readers to get a comprehensive overview of the global market. Several players are planning to focus on developing cost-effective products or services, aiming to maintain a strong foothold in the market.

The growing demand for immunization drugs and vaccines due to the extensive spread of the disease amid coronavirus will improve the prospects of the market. The enormous R&D spending by industry players to develop recombinant COVID-19 vaccine will enable speedy expansion of the market in the forthcoming years. For instance, Novavax, a pipeline candidate NVX-CoV2373 is in the phase-1 clinical study against COVID-19. The ongoing clinal trials by pharmaceutical giants for the introduction of an effective COVID vaccine will accelerate the market revenue in the foreseeable future.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations travel bans and quarantines restaurants closed all indoor events restricted over forty countries state of emergency declared massive slowing of the IT Spending market volatility falling business confidence, growing panic among the population, and uncertainty about future.

Highlights of the Report:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the Supply Chain Analytics market.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Supply Chain Analytics market

Competitive Analysis:

The Recombinant Vaccines Market Size, Share, Growth report examines competitive scenario by analyzing key players in the market. The company profiling of leading market players is included this report with Porter’s five forces analysis and Value Chain analysis. Further, the strategies exercised by the companies for expansion of business through mergers, acquisitions, and other business development measures are discussed in the report. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market.

Key questions answered in the report:

  • What will the market growth rate of Recombinant Vaccines market in 2026?
  • What are the key factors driving the global Recombinant Vaccines market?
  • Who are the key manufacturers in Recombinant Vaccines market space?
  • What are the market opportunities, market risk and market overview of the Recombinant Vaccines market?
  • What are sales, revenue, and price analysis of top manufacturers of Recombinant Vaccines market?
  • Who are the distributors, traders and dealers of Recombinant Vaccines market?
  • What are the Recombinant Vaccines market opportunities and threats faced by the vendors in the global Recombinant Vaccines industry?
  • What are sales, revenue, and price analysis by types and applications of Recombinant Vaccines market?
  • What are sales, revenue, and price analysis by regions of Recombinant Vaccines industry?

Regional Market Analysis:

This report focuses on Recombinant Vaccines Global Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2024, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.

Table Of Content:

1 Market Overview

1.1 Recombinant Vaccines Introduction

1.2 Market Analysis by Type

1.3 Market Analysis by Applications

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

3 Global Recombinant Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Recombinant Vaccines Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Recombinant Vaccines Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Recombinant Vaccines Manufacturer Market Share in 2018

3.3.2 Top 6 Recombinant Vaccines Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Recombinant Vaccines Market Analysis by Regions

4.1 Global Recombinant Vaccines Sales, Revenue and Market Share by Regions

4.1.1 Global Recombinant Vaccines Sales and Market Share by Regions (2014-2019)

4.1.2 Global Recombinant Vaccines Revenue and Market Share by Regions (2014-2019)

4.2 North America Recombinant Vaccines Sales and Growth Rate (2014-2019)

4.3 Europe Recombinant Vaccines Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Recombinant Vaccines Sales and Growth Rate (2014-2019)

4.5 South America Recombinant Vaccines Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Recombinant Vaccines Sales and Growth Rate (2014-2019)

5 North America Recombinant Vaccines by Country

5.1 North America Recombinant Vaccines Sales, Revenue and Market Share by Country

5.1.1 North America Recombinant Vaccines Sales and Market Share by Country (2014-2019)

5.1.2 North America Recombinant Vaccines Revenue and Market Share by Country (2014-2019)

5.2 United States Recombinant Vaccines Sales and Growth Rate (2014-2019)

5.3 Canada Recombinant Vaccines Sales and Growth Rate (2014-2019)

5.4 Mexico Recombinant Vaccines Sales and Growth Rate (2014-2019)

8 South America Recombinant Vaccines by Country

8.1 South America Recombinant Vaccines Sales, Revenue and Market Share by Country

8.1.1 South America Recombinant Vaccines Sales and Market Share by Country (2014-2019)

8.1.2 South America Recombinant Vaccines Revenue and Market Share by Country (2014-2019)

8.2 Brazil Recombinant Vaccines Sales and Growth Rate (2014-2019)

8.3 Argentina Recombinant Vaccines Sales and Growth Rate (2014-2019)

8.4 Colombia Recombinant Vaccines Sales and Growth Rate (2014-2019)

9 Middle East and Africa Recombinant Vaccines by Countries

9.1 Middle East and Africa Recombinant Vaccines Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Recombinant Vaccines Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Recombinant Vaccines Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Recombinant Vaccines Sales and Growth Rate (2014-2019)

9.3 Turkey Recombinant Vaccines Sales and Growth Rate (2014-2019)

9.4 Egypt Recombinant Vaccines Sales and Growth Rate (2014-2019)

9.5 Nigeria Recombinant Vaccines Sales and Growth Rate (2014-2019)

10 Recombinant Vaccines Market In Developing Conutries

11 South America Recombinant Vaccines Market Analysis by Countries

12 Competitive Landscape

13 Industry Outlook

13.1 Market Driver Analysis

13.1.2 Market Restraints Analysis

13.1.3 Market Trends Analysis

13.2 Merger, Acquisition and New Investment

13.3 News of Product Release

14 Global Recombinant Vaccines Market Forecast

15 New Project Feasibility Analysis

15.1 Industry Barriers and New Entrants SWOT Analysis

15.1.1 Porter’s Five Forces Analysis

15.1.2 New Entrants SWOT Analysis

15.2 Analysis and Suggestions on New Project Investment

Continued…

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

411045, Maharashtra, India.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245